|1|Epstein-Barr Virus Infection Mimicking Drug-Induced Hepatitis in a Critically ill Patient During Antituberculosis Therapy. (25368656)
Wang C.H.... Shen C.H.
|2|Comment on "No impact of interleukin-28B polymorphisms on spontaneous or drug-induced hepatitis delta virus clearance" by Ubaldo Visco-Comandini et al. [Dig. Liver Dis. 2014;46:348-52]. (24815081)
Keshvari M.... Alavian S.M.
|3|Comments on 'Risk factors for drug induced hepatitis with first-line antituberculosis drugs in hospitalized patients of pulmonary tuberculosis'. (24823542)
|4|A rare coexistence: drug induced hepatitis and meningitis in association with Ibuprofen. (23671551)
Nayudu S.K.... Kumbum K.
|5|Cytochrome P450 2E1 gene polymorphisms/haplotypes and anti-tuberculosis drug-induced hepatitis in a Chinese cohort. (23460870)
Tang S.... Zhan S.
|6|Hyperacute drug-induced hepatitis with intravenous amiodarone: case report and review of the literature. (24109195)
Nasser M.... McCullough P.A.
|7|Anti-tuberculosis drug-induced hepatitis in renal transplant patient with pulmonary and extra pulmonary tuberculosis. (23960791)
|8|A Case of Drug-Induced Hepatitis due to Bortezomib in Multiple Myeloma. (22916049)
Kim Y.... Min C.K.
|9|TNF-I+ genetic polymorphism -308G/A and antituberculosis drug-induced hepatitis. (22151084)
Kim S.H.... Jee Y.K.
|10|Relationship between the polymorphisms of UGT1A6 genes and anti-tuberculosis drug induced hepatic-injury]. (21586239)
Hao J.Q.... Feng F.M.
|11|Incidence, clinical and epidemiological risk factors, and outcome of drug-induced hepatitis due to antituberculous agents in new tuberculosis cases. (19535968)
Baghaei P.... Masjedi M.
|12|NAT2 and CYP2E1 polymorphisms and susceptibility to first-line anti-tuberculosis drug-induced hepatitis. (20392357)
Lee S.W.... Wu L.S.
|13|Drug-induced hepatitis and lupus during infliximab treatment for psoriasis: case report and literature review. (20338127)
Poulin Y.... ThAcrien G.
|14|The effect of GST M1 and GST T1 gene mutations on anti-tuberculous drug induced hepatic injury]. (19576039)
Guo M.... Feng F.M.
|15|Genetic polymorphisms of drug-metabolizing enzymes and anti-TB drug-induced hepatitis. (19891553)
Kim S.H.... Jee Y.K.
|16|Acute drug-induced hepatitis caused by albendazole. (18955802)
Choi G.Y.... Cha S.W.
|17|Acute drug induced hepatitis due to erlotinib. (17228132)
Ramanarayanan J.... Scarpace S.L.
|18|Drug induced hepatitis with anti-tubercular chemotherapy: challenges and difficulties in treatment. (18604033)
Kishore P.V.... Shankar P.R.
|19|Drug-induced hepatitis in an acromegalic patient during combined treatment with pegvisomant and octreotide long-acting repeatable attributed to the use of pegvisomant. (16728538)
Feenstra J.... van der Lely A.J.
|20|Drug-induced hepatitis in a patient with malignant melanoma treated with interferon alfa 2b adjuvantly who had been administered gemfibrozil in therapy. (16645237)
GrubisiA8-Cabo F.... Vrdoljak E.
|21|Role of CYP2E1 immunoglobulin G4 subclass antibodies and complement in pathogenesis of idiosyncratic drug-induced hepatitis. (16467335)
Njoku D.B.... Rose N.R.
|22|A case of acute drug-induced hepatitis. (16607204)
|23|Drug-induced hepatitis with saquinavir/ritonavir + rifampin. (15828118) |2005|
|24|Drug-induced hepatitis, drug-induced autoimmunity or classical autoimmune hepatitis: how can we differentiate? (15492907)
|25|Secular increase in the incidence rate of drug-induced hepatitis due to anti-tuberculosis chemotherapy including isoniazid and rifampicin]. (12739393)
Nagayama N.... Mohri M.
|26|Antituberculosis drug-induced hepatitis: risk factors, prevention and management. (15332488)
Hussain Z.... Husain S.A.
|27|Drug-induced hepatitis with autoimmune features during minocycline therapy. (12583618)
Abe M.... Onji M.
|28|Clinical pharmacology consultations: consultation requests may be misleading -- an organized approach to drug-induced hepatitis. (12879142)
Valois M.... Shear N.H.
|29|Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis. (12668988)
Huang Y.S.... Lee S.D.
|30|Drug-induced hepatitis with hepatic granuloma due to saridon. (12522541)
Abe M.... Onji M.
|31|Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis. (11915035)
Huang Y.S.... Lee S.D.
|32|Comment: history of drug-induced hepatitis and risk of amoxicillin/clavulanate-induced hepatotoxicity. (11793648)
|33|Effects of the enterosorbent SUMS-1 on isoniazid pharmacokinetics and lipid peroxidation in patients with pulmonary tuberculosis and drug-induced hepatic lesions]. (11508231)
Kolpakova T.A.... LiubarskiA- M.S.
|35|Nonsteroidal antiinflammatory drug-induced hepatitis. (9533071)
Crouch M.A.... Brophy D.F.
|36|Diagnostic value of T cell reactivity in drug induced hepatitis. (9917196)
|37|Immunoallergic drug-induced hepatitis: lessons from halothane. (9138123)
|38|Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitis. (9138125)
Robin M.A.... Pessayre D.
|39|Evidence of antibodies to erythromycin in serum of a patient following an episode of acute drug-induced hepatitis. (8735873)
GA^mez-LechA^n M.J.... Castell J.V.
|40|Dystonia and drug-induced hepatitis in a patient treated with clozapine. (7694924)
Worrall R.... Cullen M.
|41|Role of reactive metabolites in drug-induced hepatitis. (8551007)
|42|Antituberculosis drug-induced hepatitis and HBsAg carriers. (8369519)
Amarapurkar D.N.... Desai H.G.
|44|Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug. (3540968)
Beaune P.... Homberg J.C.
|45|Drug-induced hepatitis and lymphocyte transformation test in presence of prostaglandin inhibitor. (2871443)
Victorino R.M.... Maria V.A.
|46|Antituberculosis drug-induced hepatitis--the dangers of rechallenge. (3764619)
Monteagudo F.S.... Pillans P.I.
|47|Drug-induced hepatitis associated with anticytoplasmic organelle autoantibodies. (4029887)
Homberg J.C.... Beaugrand M.
TA8pA8lagA8 D.... Dancea S.
|49|Leukocyte migration inhibition induced by the combination of drug and a liver constituent in patients with drug-induced hepatitis. (81789)
|50|Recognition, prevention, and treatment of drug-induced hepatitis. (5766633)